Retatrutide is a synthetic peptide and a triple receptor agonist that targets the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors. This unique mechanism positions Retatrutide as a valuable compound for investigating metabolic pathways related to glucose regulation, appetite control, and energy expenditure.
This product is intended exclusively for laboratory research purposes. It is not for human or veterinary use, and not for diagnostic or therapeutic applications. All handling and experimentation should be conducted by qualified professionals in compliance with applicable regulations.
MD20 FOR 20% OFF SITEWIDE